Literature DB >> 32444779

Exploring the molecular basis of sexual dimorphism in bladder cancer.

Benjamin Pradere1,2, Shahrokh F Shariat3,4,5,6,7,8,9.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32444779     DOI: 10.1038/s41585-020-0339-3

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  3 in total

1.  A Systematic Review and Meta-Analysis of Variant Histology in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy.

Authors:  Keiichiro Mori; Mohammad Abufaraj; Hadi Mostafaei; Fahad Quhal; Pierre I Karakiewicz; Alberto Briganti; Shoji Kimura; Shin Egawa; Shahrokh F Shariat
Journal:  J Urol       Date:  2020-07-27       Impact factor: 7.450

2.  Sex-specific Differences in the Quality of Treatment of Muscle-invasive Bladder Cancer Do Not Explain the Overall Survival Discrepancy.

Authors:  Marieke J Krimphove; Julie Szymaniak; Maya Marchese; Karl H Tully; David D'Andrea; Matthew Mossanen; Stuart R Lipsitz; Kerry Kilbridge; Adam S Kibel; Luis A Kluth; Shahrokh F Shariat; Quoc-Dien Trinh
Journal:  Eur Urol Focus       Date:  2019-06-18

3.  Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study.

Authors:  Andrea Necchi; Daniele Raggi; Patrizia Giannatempo; Laura Marandino; Elena Farè; Andrea Gallina; Maurizio Colecchia; Roberta Lucianò; Andrea Salonia; Giorgio Gandaglia; Nicola Fossati; Marco Bandini; Filippo Pederzoli; Ryan Dittamore; Yang Liu; Elai Davicioni; Jeffrey S Ross; Joep J de Jong; Alberto Briganti; Francesco Montorsi; Ewan A Gibb
Journal:  Eur Urol Oncol       Date:  2020-05-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.